Decibel Cannabis Co Inc (DBCCF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Decibel Cannabis Price to Book Value: 0.6172 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 0.6172 |
| June 13, 2024 | 0.6036 |
| June 12, 2024 | 0.5971 |
| June 11, 2024 | 0.5818 |
| June 10, 2024 | 0.6125 |
| June 07, 2024 | 0.563 |
| June 06, 2024 | 0.5712 |
| June 05, 2024 | 0.5901 |
| June 04, 2024 | 0.5936 |
| June 03, 2024 | 0.6054 |
| May 31, 2024 | 0.6136 |
| May 30, 2024 | 0.6525 |
| May 29, 2024 | 0.6337 |
| May 28, 2024 | 0.7562 |
| May 24, 2024 | 0.7809 |
| May 23, 2024 | 0.8574 |
| May 22, 2024 | 0.8598 |
| May 21, 2024 | 0.8539 |
| May 20, 2024 | 0.8951 |
| May 17, 2024 | 0.9623 |
| May 16, 2024 | 0.954 |
| May 15, 2024 | 1.016 |
| May 14, 2024 | 1.001 |
| May 13, 2024 | 1.031 |
| May 10, 2024 | 0.9422 |
| Date | Value |
|---|---|
| May 09, 2024 | 0.9941 |
| May 08, 2024 | 1.002 |
| May 07, 2024 | 0.9927 |
| May 06, 2024 | 1.059 |
| May 03, 2024 | 1.056 |
| May 02, 2024 | 1.084 |
| May 01, 2024 | 1.062 |
| April 30, 2024 | 1.092 |
| April 29, 2024 | 1.041 |
| April 26, 2024 | 1.137 |
| April 25, 2024 | 1.085 |
| April 24, 2024 | 1.137 |
| April 23, 2024 | 1.190 |
| April 22, 2024 | 1.190 |
| April 19, 2024 | 1.161 |
| April 18, 2024 | 1.172 |
| April 17, 2024 | 1.207 |
| April 16, 2024 | 1.248 |
| April 15, 2024 | 1.246 |
| April 12, 2024 | 1.229 |
| April 11, 2024 | 1.178 |
| April 10, 2024 | 1.192 |
| April 09, 2024 | 1.174 |
| April 08, 2024 | 1.181 |
| April 05, 2024 | 1.148 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2879
Minimum
Nov 18 2019
3.493
Maximum
Jun 14 2021
1.172
Average
1.051
Median
Jan 28 2022
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4687 |
| Aurinia Pharmaceuticals Inc | 2.138 |
| Edesa Biotech Inc | 3.309 |
| Lexaria Bioscience Corp | 6.106 |
| Xenon Pharmaceuticals Inc | 3.167 |
Price to Book Value Related Metrics
| PS Ratio | 0.2623 |
| PEG Ratio | -0.0624 |
| Price to Free Cash Flow | 10.13 |
| Price | 0.0524 |
| Earnings Yield | -11.68% |
| Market Cap | 21.43M |
| PEGY Ratio | -0.0624 |
| Operating PE Ratio | 12.98 |